by Clinical Neuropsychologist | Friday, January 24, 2025 | Neuroimaging
ABSTRACT Intracranial pressure (ICP) monitoring is a cornerstone of neurocritical care in managing severe brain injury. However, current invasive ICP monitoring methods carry significant risks, including infection and intracranial hemorrhage, and are contraindicated...
by Clinical Neuropsychologist | Wednesday, January 22, 2025 | Neuroimaging
ABSTRACT Background and Purpose The central vein sign (CVS) is a diagnostic imaging biomarker for multiple sclerosis (MS). FLAIR* is a combined MRI contrast that provides high conspicuity for CVS at 3 Tesla (3T), enabling its sensitive and accurate detection in...
by Clinical Neuropsychologist | Tuesday, January 21, 2025 | Neuroimaging
ABSTRACT Background and purpose Prolonged length of stay (LOS) following a stroke is associated with unfavorable clinical outcomes. Factors predicting LOS in medium vessel occlusion (MeVO), impacting up to 40% of acute ischemic stroke (AIS) cases, remain...
by Clinical Neuropsychologist | Thursday, January 16, 2025 | Neuroimaging
ABSTRACT Background and Purpose MRI is crucial for multiple sclerosis (MS), but the relative value of portable ultra-low field MRI (pULF-MRI), a technology that holds promise for extending access to MRI, is unknown. We assessed white matter lesion (WML) detection on...
by Clinical Neuropsychologist | Wednesday, January 15, 2025 | Neuroimaging
ABSTRACT Background and Purpose Prolonged venous transit (PVT), derived from computed tomography perfusion (CTP) time-to-maximum (T max) maps, reflects compromised venous outflow (VO) in acute ischemic stroke due to large vessel occlusion (AIS-LVO). Poor VO is...
by Clinical Neuropsychologist | Monday, January 13, 2025 | Neuroimaging
ABSTRACT Background and Purpose While the pulsatility index (PI) measured by transcranial Doppler (TCD) has broader associations with outcomes in neurocritical care, its use in monitoring delayed cerebral infarction (DCI) in patients with aneurysmal subarachnoid...
